Skip to content

Stemcyte, Inc.

United StatesFDA applicant, unverified

Devices
2

What Stemcyte, Inc. makes

Stemcyte, Inc. manufactures Bonvadis®, a medical device intended for wound care and tissue regeneration, and Bonvadis Topical Cream, designed for topical application to promote healing in chronic wounds. Both products are formulated to support skin repair and reduce infection risk in affected areas.

The company’s portfolio is regulated under Class II (U) devices in the U.S. and is listed in the FDA’s 510(k) clearance registry. The manufacturer is based in the United States.

AI-generated from registry data, 1 Oct 2026. Not verified by deviCERTS or the manufacturer.

Catalogue2

Newest first, rows 1-2 of 2

  • Bonvadis® Ref K232655

    Active Regimes: 510(k) Registry: 510(k) Class:—

  • Bonvadis Topical Cream Ref K212554

    Active Regimes: 510(k) Registry: 510(k) Class:—

Frequently asked questions

How many devices does Stemcyte, Inc. have in the registry?

The registry currently lists 2 devices for Stemcyte, Inc.. Devices recorded under merged duplicate company entries are counted once.

Which registries list Stemcyte, Inc.'s devices?

Among its 2 most recently registered devices, Stemcyte, Inc. has devices listed in FDA 510(k) (2 devices).

What are the newest devices from Stemcyte, Inc. in the registry?

The most recently registered devices listed for Stemcyte, Inc. include Bonvadis® and Bonvadis Topical Cream.

Generated automatically from registry data and not verified by a human reviewer.